Motion Sickness Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, China, Germany - Size and Forecast 2024-2028

Motion Sickness Drugs Market Size 2024-2028

The motion sickness drugs market size is forecast to increase by USD 139.5 million, at a CAGR of 4.37% between 2023 and 2028. The market's growth is propelled by various factors, including the widespread availability of over-the-counter (OTC) medications in diverse dosage forms, tailored to meet consumer preferences. Additionally, the global surge in travel and tourism has significantly augmented the demand for these remedies. However, the market grapples with persistent challenges, such as the emergence of nonpharmacological treatments that compete with traditional medications. Moreover, the introduction of generic alternatives presents a threat, impacting market dynamics. Concerns regarding the adverse effects associated with motion sickness medications further emphasize the necessity for continuous innovation and stringent regulatory oversight within the industry. This ensures consumer safety and satisfaction while maintaining the market's resilience amid evolving preferences and emerging competition. Industry stakeholders must adapt to these challenges by focusing on product innovation, quality assurance, and compliance with regulatory standards to sustain growth in this competitive landscape. It also includes an in-depth analysis of market trends and analysis, market growth analysis and challenges. Furthermore, the report includes historic market data from 2018 - 2022.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, View Report Sample

Market Dynamic and Customer Landscape

The market addresses unmet healthcare needs related to the medical condition of motion sickness caused by multi-axial motion and acceleration, leading to uncomfortable Sensation and temporary discomfort, especially affecting the eyes. This condition often induces anxiety in travelers and individuals exposed to motion-heavy scenarios, including those in virtual reality environments. The market provides various medicines, including the Reliefband and Reliefband Sport, targeting acetylcholine receptors and are available as prescription drugs for cancer patients, females, and others. These solutions cater to developed economies with specific demand dynamics and are accessible through various distribution channels, including online pharmacies. Additionally, the market explores options like wearable relief bands and traditional medicines with different routes of administration, such as transdermal drugs and oral drugs, to effectively manage motion sickness. 

Key Driver

The availability of over-the-counter (OTC) drugs is notably driving the market growth. The global motion sickness drug market is largely served by generic drugs, available both by prescription and over-the-counter. Anticholinergics and antihistamines are considered first-line treatments for controlling and preventing symptoms associated with the disease. Several antihistamines are available over the counter and can be used by pediatric patients. These drugs are used primarily to prevent symptoms of the disease, not as a treatment. OTC medicines are medicines sold directly to patients or consumers without a doctor's prescription. The availability of these OTC medicines increases their availability and affordability, allowing patients the freedom to self-medicate symptoms associated with mild illness. In addition, the availability of OTC medicines reduces the financial burden associated with drug treatment, as prescriptions are no longer required to purchase these medicines.

Moreover, Antihistamines are commonly used to prevent and treat the disease. First-generation antihistamines include diphenhydramine, dimenhydrinate, meclizine, chlorpheniramine, and promethazine. Second-generation antihistamines include cetirizine and fexofenadine. However, they are not as effective as first-generation antihistamines because they have insufficient central cholinergic activity. The over-the-counter availability of antihistamines has increased the acceptance of antihistamines among patients suffering from the disease, thereby driving the growth of the market. 

Significant Trends

The increased penetration of online channels is the major trend shaping the market. Online drug sales have become increasingly popular in recent years due to their convenience. The COVID-19 pandemic has increased the demand for medicines such as  the disease medicine through online channels. The rise of telemedicine and virtual consultations has made it easier for patients to receive prescriptions online.

Moreover, online platforms offer an easy and convenient way for consumers to purchase medicines from the comfort of their own homes. With the prevalence of technology and the internet, more and more people are adopting e-commerce platforms for pharmaceuticals, such as motion sickness remedies, which is expected to drive the growth of the global motion sickness remedies market during the forecast period.

Major Challenge

The launch of generics may impede the growth of the market. The introduction of generic drugs in recent years has adversely affected the growth of the global motion sickness drug market. After the introduction of generic drugs, the branded version will be marketed. Generic drugs are cheaper drugs that contain the same active ingredients as the original drug. These drugs enter the market shortly after branded drugs lose their patent exclusivity.

Moreover, after patent exclusivity is lost, generic product competition increases, leading to lower sales of branded drugs as generic competitors enter the market at lower prices for the same products. This also increases the threat of new market entrants, which in turn impacts the market position of incumbent players. Once these generic drugs are introduced in developed countries, they reach developing countries in a short period of time. Such incidents are estimated to adversely affect the markets of developing countries during the forecast period.

Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Market Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

• Abbott Laboratories: The company offers motion sickness drug called Avomine tablet composed of Promethazine.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

• Amneal Pharmaceuticals Inc.
• Baxter International Inc.
• CVS Health Corp.
• DM Pharma Marketing Pvt. Ltd.
• GlaxoSmithKline Plc
• Hylands
• Lupin Ltd.
• Merck KGaA
• Myungmoon Pharm Co. Ltd.
• Novartis AG
• Perrigo Co. Plc
• Prestige Consumer Healthcare Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Tivic Health Systems Inc.
• Viatris Inc.
• WellSpring Pharmaceutical Corp.
• Zenomed Healthcare Pvt. Ltd.
• Zydus Lifesciences Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation 

The market share growth by the antihistamines segment will be significant during the forecast period. This segment includes cinnarizine, promethazine hydrochloride, promethazine thecate, and meclizine. First-generation antihistamines have antiallergic, antitussive, antipruritic, and antiemetic effects. The antiemetic effect was attributed to the blockade of histamine 1 receptors (H1) and muscarinic receptors. All four drugs have similar pharmacological activity. However, there are no comparative studies.

Get a glance at the market contribution of various segments View the PDF Sample

The antihistamines segment was valued at USD 283.40 million in 2018. The over-the-counter availability of antihistamines has improved the availability and affordability of antihistamines for the general public. Various antihistamines are available to prevent and treat the disease. In particular, antihistamines with central cholinergic inhibitory properties have been shown to be effective in preventing or treating the disease. This fact suggests that the action of antihistamines on disease is not due to histamine-blocking effects but due to peripheral and central anticholinergic effects. First-generation antihistamines act both centrally and peripherally. Thus, they are widely used by patients suffering from the disease, which is driving the growth of the segment.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. This high proportion is due to the existence of large pharmaceutical companies offering both branded and generic medications and the existence of an adequate regulatory framework for new drug approval in the region. Additionally, tourism and adventure sports that can cause the disease are on the rise in the region, increasing the demand.

Moreover, the rising disposable income of people has led more and more patients to opt for treatment, contributing to the growth of the North American market. Moreover, increasing focus on investment in R&D activities by major companies to maintain their market position is expected to have a positive impact on the market in the coming years. Pfizer and Mylan are among the leading players in the region.

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Product Outlook 
  • Antihistamines
  • Anticholinergics
• Distribution Channel 
  • Offline
  • Online
• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World
    • Australia
    • Argentina
    • Rest of the world

You may also interested in below market reports:

• Antiemetic Drug Market Antiemetic Drug Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast
• Transdermal Drug Delivery Market Transdermal Drug Delivery Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, Japan - Size and Forecast
• Obsessive-Compulsive Disorder (OCD) Drugs Market Obsessive-Compulsive Disorder (OCD) Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, China, Japan - Size and Forecast 

Market Analyst Overview

The market is influenced by various factors, including unmet healthcare needs, particularly for individuals prone to motion sickness. This medical condition involves multi-axial motion that can lead to discomfort, anxiety, and unpleasant Temporary Sensation, especially affecting pregnant women, children, and travelers. Nausea, increased salivation, belching, and sweating are common symptoms. Pharmacological therapies like antihistaminic and anticholinergic drugs play a pivotal role in alleviating these symptoms. Healthcare systems worldwide cater to diverse needs, including motion sickness treatment for cancer patients, females, and travelers, especially during the COVID-19 pandemic. Popular motion sickness treatments include the Reliefband and Reliefband Sport, which target acetylcholine receptors like scopolamine and prochlorperazine, providing relief for individuals in motion-heavy scenarios. The demand dynamics vary, with regions like the Virgin Islands and Saint Maarten relying on prescription drugs and seeking effective solutions through the motion sickness drugs market.

Moreover, the market dynamics include the incidence of motion sickness, product approvals, drug classes (oral and transdermal), and distribution channels such as hospital pharmacies, drug stores, retail pharmacies, and online providers. The demand for wearable relief bands, traditional medicines, and route of administration preferences also influence the market, especially in developed economies. With the rising use of virtual reality and the ongoing COVID-19 pandemic impacting travel patterns, the motion sickness treatment market continues to evolve to meet diverse healthcare needs. The market is driven by a range of factors, including the physiological responses to motion like acceleration, uncomfortable sensations, and hyperventilating. These sensations, especially those affecting the eyes and leading to temporary discomfort, are addressed by antihistaminic drugs and other pharmaceutical solutions. The market dynamics encompass the pharmaceutical industry's innovations in drug classes such as transdermal drugs and oral medications, available in drug stores, retail pharmacies, and online platforms.

Additionally, the market is driven by unmet healthcare needs due to motion sickness, particularly caused by multi-axial motion and acceleration, leading to discomfort and anxiety. The market trends include the rise in demand for wearable relief bands like Reliefband and Reliefband Sport, targeting acetylcholine receptors. However, challenges persist in the distribution channels, regulatory hurdles for prescription drugs, and the need to address specific demographics like cancer patients, females, and individuals in virtual reality scenarios amidst the Coronavirus pandemic. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

View PDF Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market report during the forecast period
• Detailed information of market analysis and report on factors that will drive the growth of the market between 2024 and 2028
• Precise estimation of the size of the market and its contribution in focus to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch